PRECIGEN INC's ticker is PGEN and the CUSIP is 74017N105. A total of 176 filers reported holding PRECIGEN INC in Q3 2021. The put-call ratio across all filers is 1.22 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $10,500 | -1.4% | 7,500 | 0.0% | 0.00% | 0.0% |
| Q3 2023 | $10,650 | +23.5% | 7,500 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $8,625 | +8.5% | 7,500 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $7,950 | -30.3% | 7,500 | -50.0% | 0.00% | 0.0% |
| Q4 2022 | $11,411 | -28.7% | 15,000 | +100.0% | 0.00% | -50.0% |
| Q3 2022 | $16,000 | +60.0% | 7,500 | 0.0% | 0.00% | +100.0% |
| Q2 2022 | $10,000 | -37.5% | 7,500 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $16,000 | -42.9% | 7,500 | 0.0% | 0.00% | -50.0% |
| Q4 2021 | $28,000 | -24.3% | 7,500 | 0.0% | 0.00% | -33.3% |
| Q3 2021 | $37,000 | -27.5% | 7,500 | 0.0% | 0.00% | -25.0% |
| Q2 2021 | $51,000 | -1.9% | 7,500 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $52,000 | -30.7% | 7,500 | 0.0% | 0.00% | -42.9% |
| Q4 2020 | $75,000 | +177.8% | 7,500 | 0.0% | 0.01% | +133.3% |
| Q3 2020 | $27,000 | -27.0% | 7,500 | 0.0% | 0.00% | -25.0% |
| Q2 2020 | $37,000 | +54.2% | 7,500 | 0.0% | 0.00% | +33.3% |
| Q1 2020 | $24,000 | – | 7,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Patient Capital Management, LLC | 13,753,176 | $19,529,510 | 1.15% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 2,078,220 | $2,951,072 | 0.60% |
| EMFO, LLC | 425,000 | $603,500 | 0.57% |
| Opaleye Management Inc. | 928,500 | $1,318,470 | 0.43% |
| First Washington CORP | 646,575 | $918,137 | 0.37% |
| Fore Capital, LLC | 426,791 | $606,043 | 0.26% |
| SANDERS MORRIS HARRIS LLC | 410,000 | $582,200 | 0.12% |
| MSD Partners, L.P. | 960,000 | $1,363,200 | 0.11% |
| Virtus ETF Advisers LLC | 79,754 | $113,251 | 0.07% |
| CHIRON CAPITAL MANAGEMENT, LLC | 55,850 | $79,307 | 0.07% |